For the full versions of these articles see bmj.com benefit and should not be given for this purpose. The evidence for added calcium in the prevention of hypertensive disorders is conflicting and confusing, and more research is needed in this area.
This is one of a series of BMJ summaries of new guidelines based on the best available evidence; they highlight important recommendations for clinical practice, especially where uncertainty or controversy exists Further information about the guidance, a list of members of the guideline development group, and the supporting evidence statements are in the full version on bmj.com.
Why read this summary?
Hypertensive disorders of pregnancy cover a spectrum of conditions, including chronic (pre-existing) hypertension, pre-eclampsia, and gestational hypertension (box 1). These conditions are associated with increased perinatal mortality and morbidity. Hypertensive disorders cause one in 50 stillbirths in normal babies and 10% of all preterm births. They contribute to a third of cases of severe maternal morbidity. 1 Pre-eclampsia is one of the most common causes of maternal death in the United Kingdom. 2 This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on how to manage hypertensive disorders during pregnancy. 3 Recommendations NICE recommendations are based on systematic reviews of best available evidence and explicit consideration of cost effectiveness. When minimal evidence is available, recommendations are based on the Guideline Development Group's experience and opinion of what constitutes good practice. Evidence levels for the recommendations are in the full version of this article on bmj.com.
Reducing the risk of hypertensive disorders in pregnancy
• Advise pregnant women of their risk of developing hypertensive disorders during pregnancy (in particular pre-eclampsia; see box 2) and of the need to seek immediate advice from a healthcare professional if they experience symptoms of preeclampsia (severe headache; problems with vision, such as blurring or flashing before the eyes; severe pain just below the ribs; vomiting; sudden swelling of face, hands, or feet).
• Advise women with at least one high risk factor for pre-eclampsia or at least two moderate risk factors for pre-eclampsia (box 2) to take 75 mg of aspirin daily from 12 weeks until the birth of the baby.
• Although several drugs (nitric oxide donors, progesterone, diuretics, and low molecular weight heparin) and vitamin and nutrient supplements (such as vitamin C, vitamin E, folic acid, magnesium, fish oils, algal oils, and garlic) have been studied as preventive treatments for hypertensive disorders, these have not shown 
Antenatal care
• Antihypertensive treatment should be offered but be dependent on pre-existing treatment, side effect profiles, and teratogenicity.
• If women taking angiotensin converting enzyme inhibitors or angiotensin II receptor blockers become pregnant, stop these drugs and offer alternatives.
• Aim to keep blood pressure lower than 150/100 mm Hg in pregnant women with uncomplicated chronic hypertension but do not lower diastolic blood pressure below 80 mm Hg.
• Schedule additional antenatal consultations on the basis of the woman and her baby's needs.
• Do not offer birth before 37 weeks' gestation if blood pressure is lower than 160/110 mm Hg, with or without antihypertensive treatment.
New onset hypertension during pregnancy Assessment of proteinuria
• To diagnose pre-eclampsia and distinguish it from gestational hypertension, use an automated reagent strip reading device or spot urinary protein:creatinine ratio for estimating proteinuria in secondary care.
• If an automated reagent strip reading device is used to detect proteinuria and a result of 1+ or more is obtained, use a spot protein:creatinine ratio or 24 hour urine collection to quantify proteinuria.
• Diagnose clinically relevant proteinuria if the urinary protein:creatinine ratio is greater than 30 mg/mmol or a validated 24 hour urine collection shows greater than 300 mg protein.
• Where 24 hour urine collection is used to quantify 
PRACTICE
or moderate hypertension using the same criteria as for the antenatal period (even if regional analgesia is being considered).
• If low dose epidural analgesia or combined spinal epidural analgesia is needed in women with severe pre-eclampsia, do not preload with intravenous fluids.
Medical management of severe hypertension or severe pre-eclampsia in critical care
• The full guideline includes recommendations on criteria for referral to critical care, management of severe hypertension (including antihypertensive treatment and blood pressure measurement), anticonvulsants, corticosteroids (use betamethasone for fetal lung maturation but do not use betamethasone or dexamethasone for treatment of HELLP syndrome (box 1)), and fluid balance and volume expansion.
• Choose the mode of birth (induction of labour or caesarean section) according to the clinical circumstances and the woman's preference.
Postnatal care and follow-up care
• The full guideline includes recommendations on antihypertensive treatment and blood pressure measurement in the postnatal period.
• Tell women that labetalol, nifedipine, enalapril, captopril, atenolol, and metoprolol have no known adverse effects on babies receiving breast milk.
• Tell women that there is insufficient evidence on the safety of angiotensin II receptor blockers, amlodipine, and angiotensin converting enzyme inhibitors other than enalapril and captopril in babies receiving breast milk.
• Offer a medical review at the postnatal review (six to eight weeks after the birth).
• At transfer to community care tell women who have had gestational hypertension or pre-eclampsia that they have an increased risk of these conditions occurring in future pregnancies and an increased risk of developing high blood pressure and its complications in later life.
Overcoming barriers
Management of hypertensive disorders in pregnancy is thought to vary considerably, with many practices reflecting tradition rather than being evidence based. The recommendations and the supporting evidence should give healthcare professionals confidence to reduce the frequency of unnecessary tests and assessments in women with mild or moderate disease, yet emphasise an escalating approach to care that is centred more on individual women. The guidance may reduce interventions that result in morbidity, such as preterm birth, and may better target interventions that are likely to benefit the woman and her baby. Such changes are more likely to be adopted by clinicians, as are the many cost saving aspects of this guidance. Informed dialogue is another powerful driver of change: emphasising prevention, increasing information for women themselves, and increasing awareness of signs and symptoms from existing NICE guidance for routine antenatal care 4 should empower pregnant women to have such dialogue with their healthcare professionals.
Contributors: CV and MAM wrote the initial draft of the article using material produced collectively by the guideline development group and revised the draft after receipt of comments from MQA, LMN, DJ, SW, and the series editor. All authors approved the final version for publication. MAM is guarantor. 
The problem
Fatigue is a normal part of life, but it can also be a symptom of disease, including serious illnesses. It is a common complaint in primary care, exceeded only by complaints of cough. 1 Five to seven per cent of patients attending primary care have a primary complaint of fatigue, with this proportion being remarkably consistent across Western countries [2] [3] [4] [5] and over time. 4 The proportion of patients presenting with fatigue as an additional complaint is nearly three times as high. 3 6 Almost three quarters of consultations for fatigue are isolated episodes, with no follow-up consultations on the subject. 5 This is presumably because most patients' fatigue improves, 7 especially if there is a time limited explanation, such as a recent infection. 8 9 It is not surprising, therefore, that general practitioners perform investigations in only half of patients complaining of fatigue 10 and that few of these tests yield abnormal results. 10 11 Even so, the high incidence of the fatigue complaints means that laboratory tests for fatigue account for almost 5% of the total number of laboratory tests ordered by general practitioners. 12 The likelihood of finding a diagnosis A diagnosis is made in less than half of patients with fatigue; furthermore, many of the diagnoses are descriptive, such as stress, or are one of the many synonyms for fatigue itself. 6 Patients understand that an underlying identifiable disease may not be present, 6 though patients' and doctors' beliefs are sometimes mismatched, with a higher proportion of doctors than patients considering the particular problem to be psychological. 13 Precipitating factors for consultation can be stressful life events (underlying about two thirds of fatigue complaints)-for example, work disputes, family problems, bereavement, or financial difficulties; or they can be illnesses such as respiratory tract infections. Hypothyroidism and anaemia are identified in under 3% of patients. 10 Other conditions, such as Addison's disease, renal failure, liver failure, carbon monoxide poisoning, coeliac disease, pregnancy, domestic abuse, and sleep apnoea are all rare, though each may (rarely) present with fatigue as a predominant complaint. Indeed, almost any condition can do so.
History and examination
After the initial history taking, ask questions about the main organ systems, particularly about bleeding (menorrhagia, gastrointestinal), gastrointestinal symptoms, urinary symptoms (including polyuria and polydipsia), quality and length of sleep (sleep apnoea being characterised by episodes of night-time breathlessness, daytime sleepiness, and often snoring), recent infections, joint pains or swelling, and mental health problems including concentration, motivation, stressful events, and mood. Review prescribed and over the counter medications for iatrogenic fatigue and ask specifically about alcohol consumption. Examine the patient,
RATIONAL TESTING
Investigating fatigue in primary care 
LEARNING POINTS
Tiredness is a common complaint, reported in 5-7% of general practice encounters Investigations may exclude diagnosis and reassure the patient, but they have a low rate of identifying any underlying disease Investigations are warranted in those who have not recovered after one month or whose initial presentation is atypical or is associated with "red flag" symptoms Be alert for important but easily missed conditions such as carbon monoxide poisoning, coeliac disease, pregnancy, and sleep apnoea Further evidence is needed to establish best practice in the investigation of the tired patient 
What is the next investigation?
Rational investigation aims to allow most patients to forgo testing and improve spontaneously, while identifying the few patients with underlying disease reasonably quickly. Younger patients are less likely to have underlying disease, as are patients who consult frequently. 1 10 Recent infection or stressful events can justify deferral of testing. Time can be a diagnostician as well as a healer, although it is probably advisable to offer a specific time for review rather than a vague "return if you don't improve." Take action accordingly when red flag symptoms or signs are detected; most are obvious (box).
Investigations are warranted in those who have not recovered at about four weeks, 15 16 although they may be warranted at presentation if this is atypical (an older patient or a patient who consults infrequently) 17 or if clinical features suggest a diagnosis (such as polyuria and polydipsia). Clinical intuition has also been shown to have a useful role: the "art of general practice" is in noting a slightly unusual presentation from knowledge of the individual. 18 First line investigations should be targeted at picking up the relatively common diagnoses. Evidence from one randomised trial suggests that a limited set of blood tests (haemoglobin, erythrocyte sedimentation rate, glucose, and thyroid stimulating hormone) is almost as useful diagnostically as a more extensive set of tests. 15 Whether mild hyperglycaemia causes fatigue is not clear, but one study of fatigue complaints in primary care found abnormalities of blood glucose more often than anaemia or hypothyroidism. 15 The National Institute for Health and Clinical Excellence also recommends testing for coeliac disease in people with persistent fatigue, even when no other suggestive symptoms are present. 19 Depending on the circumstances, additional first line tests may be appropriate (table) .
If first line tests are normal, a period of watchful waiting can sensibly follow. If tiredness has persisted for three months or if further suggestive symptoms have developed, then a second line of testing is reasonable. If tiredness persists for at least four months without a clear explanation, a diagnosis of chronic fatigue syndrome should be considered. 20 Referral may be indicated if the patient or doctor continues to be concerned.
Outcome
In this case, as the patient has no red flag or suggestive symptoms and no abnormal findings, the likely temporary nature of the fatigue is discussed, together with some of the 
